Stay updated on VAX-24 Safety and Immunogenicity in Adults Clinical Trial

Sign up to get notified when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the VAX-24 pneumococcal vaccine study is now displayed instead of an error page. It includes the study design, participant criteria and locations, outcome measures, results publication, and supporting documents.
    Difference
    57%
    Check dated 2026-11-10T16:45:01.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T16:52:38.000Z thumbnail image
  3. Check
    23 days ago
    Change Detected
    Summary
    A sitewide NIH notice about a terminology transition appeared, and the displayed site revision changed from v3.7.1 to v3.7.2. The study page continues to show a 403 error rather than trial details.
    Difference
    1%
    Check dated 2026-10-20T16:58:09.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T17:12:39.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error instead of the study details. This indicates restricted access or a server-side access problem affecting how the record is displayed.
    Difference
    19%
    Check dated 2026-09-22T22:33:29.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.6 to v3.7.0, signaling a new version of the study details page. This update appears to be a metadata/version change rather than a substantive alteration to the study data or descriptions.
    Difference
    0.1%
    Check dated 2026-09-15T20:29:44.000Z thumbnail image

Stay in the know with updates to VAX-24 Safety and Immunogenicity in Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.